Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Berritt

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Nature Communications|August 26, 2025
Predictive design of crystallographic chiral separationRokas Elijošius, Emma King-Smith, Felix A Faber, et al.
Journal of Medicinal Chemistry|June 17, 2026
Synthetic Approaches to the New Drugs Approved During 2024Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Journal of Medicinal Chemistry|March 15, 2024
Synthetic Approaches to the New Drugs Approved During 2022Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Journal of Medicinal Chemistry|February 3, 2025
Synthetic Approaches to the New Drugs Approved during 2023Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Science (New York, N.Y.)|January 3, 2015
Organic chemistry. Nanomole-scale high-throughput chemistry for the synthesis of complex moleculesAlexander Buitrago Santanilla, Erik L Regalado, Tony Pereira, et al.
Journal of Medicinal Chemistry|March 30, 2021
Synthetic Approaches to the New Drugs Approved during 2019Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
Journal of Medicinal Chemistry|July 14, 2022
Synthetic Approaches to the New Drugs Approved During 2020Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
Journal of Medicinal Chemistry|August 1, 2023
Synthetic Approaches to the New Drugs Approved During 2021Emma L McInturff, Scott P France, Carolyn A Leverett, et al.
The Journal of Organic Chemistry|July 18, 2025
Development of a Scalable Synthesis of a HPK1 Inhibitor Featuring a Direct α-Arylation of Boc-Protected <i>N,N</i>-Dimethylamine by Palladium-Mediated Negishi Cross-CouplingDahui Zhou, Matthew Del Bel, Thomas Knauber, et al.
Journal of Medicinal Chemistry|December 9, 2024
Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of CancerRebecca A Gallego, Sujin Cho-Schultz, Matthew Del Bel, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Nature Communications|August 26, 2025
Predictive design of crystallographic chiral separationRokas Elijošius, Emma King-Smith, Felix A Faber, et al.
Journal of Medicinal Chemistry|June 17, 2026
Synthetic Approaches to the New Drugs Approved During 2024Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Journal of Medicinal Chemistry|March 15, 2024
Synthetic Approaches to the New Drugs Approved During 2022Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Journal of Medicinal Chemistry|February 3, 2025
Synthetic Approaches to the New Drugs Approved during 2023Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Science (New York, N.Y.)|January 3, 2015
Organic chemistry. Nanomole-scale high-throughput chemistry for the synthesis of complex moleculesAlexander Buitrago Santanilla, Erik L Regalado, Tony Pereira, et al.
Journal of Medicinal Chemistry|March 30, 2021
Synthetic Approaches to the New Drugs Approved during 2019Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
Journal of Medicinal Chemistry|July 14, 2022
Synthetic Approaches to the New Drugs Approved During 2020Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
Journal of Medicinal Chemistry|August 1, 2023
Synthetic Approaches to the New Drugs Approved During 2021Emma L McInturff, Scott P France, Carolyn A Leverett, et al.
The Journal of Organic Chemistry|July 18, 2025
Development of a Scalable Synthesis of a HPK1 Inhibitor Featuring a Direct α-Arylation of Boc-Protected <i>N,N</i>-Dimethylamine by Palladium-Mediated Negishi Cross-CouplingDahui Zhou, Matthew Del Bel, Thomas Knauber, et al.
Journal of Medicinal Chemistry|December 9, 2024
Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of CancerRebecca A Gallego, Sujin Cho-Schultz, Matthew Del Bel, et al.
Pageof 5